Latest Strategic Pivot News

Livium Ltd has completed its strategic pivot to focus on recycling clean energy waste, reporting solid Q1 FY26 results and securing a significant capital raise to fuel expansion into battery, solar panel, and rare-earth element recycling.

BSA Limited’s Q1 FY2026 results reveal a sharp revenue drop following the expiration of its key nbn contract, alongside a major workforce reduction and strategic pivot.

Aspermont Limited reports its 37th consecutive quarter of subscription growth, launching its Mining-IQ AI platform and securing a landmark $550k contract with Rio Tinto.

Barton Gold Holdings has advanced its South Australian gold assets with key drilling upgrades, a low-cost mill restart feasibility study, and a $15 million equity placement led by Franklin Templeton. The company is poised to transition from explorer to producer by late 2026.

Aspermont Limited reports a milestone $11.2 million annual recurring revenue with its new Mining-IQ platform gaining traction through a landmark Rio Tinto contract. The company also strengthens its balance sheet with a $2.8 million capital raise, setting the stage for accelerated growth.

Cluey Ltd has reported its strongest-ever underlying EBITDA alongside improved cash flow, while ramping up investments in AI-powered product development set to launch in 2026.

Locate Technologies has ended its Australian ATM Facility, initiated a new NZ$10 million facility in New Zealand, and proposed a share buy-back pending shareholder approval, aligning with its Bitcoin Treasury ambitions.

Peppermint Innovation Ltd reports strong quarterly progress with new payment functionalities live, a key merchant licence granted, and a strategic pivot toward AI-driven lending.

COSOL Limited reports a $7-8 million revenue shortfall in H1 FY26 amid macroeconomic pressures but pivots towards higher-margin Asset Management as a Service contracts and cost efficiencies to stabilize performance.

Wingara AG reports a modest cash position of $302,000 as it winds down processing operations and seeks fresh transaction opportunities following the termination of its TerraFirma deal.

Patrys Limited has raised $1.77 million through a fully underwritten entitlement offer to fund preclinical studies and business development for its deoxymab therapeutic antibodies. The company also completed a capital consolidation and held a successful AGM, signaling a strategic pivot into immunology and inflammation.

Harmoney has reaffirmed its FY26 profit guidance, aiming for a $12 million cash NPAT, while unveiling a new secured auto loan product designed to disrupt the car finance market.